Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia: Effects of Various Interventions

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.11, 2001-11, pp. : 1079-1090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of Life in Sexually Active Men with Symptomatic Benign Prostatic Hyperplasia: Effects of Treatment

By Daly Mel P.

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 219-230

Adis International

Access to resources Recommend Favorite

Treatment of Benign Prostatic Hyperplasia in Patients with Cardiovascular Disease

By Santillo Vincent M. Lowe Franklin C.

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 795-805

Adis International

Access to resources Recommend Favorite

Safety of anticholinergics in patients with benign prostatic hyperplasia

By Athanasopoulos Anastasios Mitropoulos Dionisios Giannitsas Konstantinos Perimenis Petros

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 473-479

Informa Healthcare

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia

By Ekman P.

Drug Safety, Vol. 18, Iss. 3, 1998-03 ,pp. : 161-170

Adis International

Access to resources Recommend Favorite

Intraprostatic botulinum toxin A appears to be beneficial for patients with benign prostatic hyperplasia

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite